Drug details

Adhansia XR (methylphenidate hydrochloride extended-release capsules)

type of Stimulants, ADHD Agents

Adhansia XR (methylphenidate hydrochloride) is a central nervous system (CNS) stimulant indicated for the treatment of Attention Deficit Hyperactivity Disorder (ADHD) in patients 6 years and older. Adhansia XR is available in generic form.

This drug may have the following side effects:

• hives,
• difficulty breathing,
• swelling of your face, lips, tongue, or throat,
• lightheadedness,
• chest pain,
• numbness,
• hostility,
• aggression,
• trouble breathing,
• hallucinations,
• paranoia,
• pain,
• unexplained wounds,
• cold feeling,
• new behavior problems,
• skin color changes (pale, red, or blue appearance) in your fingers or toes, and
• penis erection that is painful or last 4 hours or longer

The following drugs are related to Adhansia XR, either as a replacement or used together:

• Adderall (amphetamine, dextroamphetamine mixed salts)
• Adderall XR (amphetamine, dextroamphetamine mixed salts)
• Strattera (atomoxetine hcl)
• Concerta (methylphenidate extended-release tablets)
• Desoxyn (methamphetamine hydrochloride)
• Dexedrine Spansule (dextroamphetamine capsules)
• Focalin XR (dexmethylphenidate hydrochloride)
• Focalin (dexmethylphenidate hydrochloride)
• Zenzedi (dextroamphetamine sulfate tablets, usp)
• Vyvanse (lisdexamfetamine dimesylate)
• Ritalin (methylphenidate hcl)
• Ritalin LA (methylphenidate hydrochloride extended-release capsules)